serrawettin w2 has been researched along with plasminogen activator inhibitor 2 in 1 studies
| Studies (serrawettin w2) | Trials (serrawettin w2) | Recent Studies (post-2010) (serrawettin w2) | Studies (plasminogen activator inhibitor 2) | Trials (plasminogen activator inhibitor 2) | Recent Studies (post-2010) (plasminogen activator inhibitor 2) |
|---|---|---|---|---|---|
| 10 | 0 | 5 | 106 | 1 | 47 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anthoni, U; Christophersen, C; Eberl, L; Givskov, M; Lindum, PW; Molin, S | 1 |
1 other study(ies) available for serrawettin w2 and plasminogen activator inhibitor 2
| Article | Year |
|---|---|
N-Acyl-L-homoserine lactone autoinducers control production of an extracellular lipopeptide biosurfactant required for swarming motility of Serratia liquefaciens MG1.
Topics: 4-Butyrolactone; Amino Acid Sequence; Cell Movement; Conserved Sequence; Extracellular Space; Genes, Bacterial; Lipoproteins; Molecular Sequence Data; Molecular Structure; Peptide Synthases; Peptides, Cyclic; Sequence Homology, Amino Acid; Serratia; Surface-Active Agents | 1998 |